5 Recruiting Waldenstrom Macroglobulinemia Clinical Trials in Massachusetts
Explore active waldenstrom macroglobulinemia research studies enrolling across Massachusetts. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Waldenstrom Macroglobulinemia Studies in Massachusetts
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
📍 Beth Israel Deaconness Medical — Boston, Massachusetts
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Ibrutinib + Venetoclax in Untreated WM
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Loncastuximab Tesirine in WM
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Epcoritamab in Previously Treated WM
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
📍 Dana Farber Cancer Institute (Data Collection and Specimen Analysis) — Boston, Massachusetts
View Study & Checklist ➔